Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This trial will explore giving standard dose chemotherapy and radiation therapy to sites of
disease including all lymph nodes involved with HPV-positive oropharyngeal cancer, but
administer lower doses of radiation therapy to the lymph nodes that are not known to be
involved with cancer. By doing so, it is hypothesized that there will be equally good long
term loco-regional and distant disease control but will reduced long term treatment side
effects and improved quality of life in persons living well beyond their cancer treatment.